pr-inside.com
Print
CuraGen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

CuraGen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report released



companiesandmarkets.com
2009-11-10 00:33:04 - CuraGen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com

www.companiesandmarkets.com/Summary-Company-Profile/curagen-corp ..

CuraGen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

CuraGen Corporation, a biopharmaceutical development company is engaged in the research, development and commercialization of novel therapeutics used for the treatment of cancer. The company intends to advance its cancer treatments belinostat and CR011-vcMMAE, by means of clinical development. Its two products include CR011-vcMMAE, for the treatment of metastatic

 

 

melanoma, breast cancer, and brain tumors, while CR014-vcMMAE is for the treatment of ovarian cancer and renal cell carcinoma. It also maintains a portfolio of early stage assets, including proteins, antibodies and small molecules for the treatment of cancer. The company is headquartered at Brandford, Connectticut, United States

The CuraGen Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.

Scope

- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.

Author:
Mike King
e-mail
Web: http://www.companiesandmarkets.com
Telefon: London: +44 (0) 203 086 8600




Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.